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SUMMARY
Matching individuals reported to a sentinel surveillance scheme for hepatitis C between 2000
and 2005 to individuals with a hospital episode for hepatitis C-related liver disease in the
same hospitals, we estimated that the number of cases of hepatitis C-related end-stage liver
disease in these English hospitals was 42% (597/419) higher than Hospital Episode Statistics
(HES) would indicate. Further, matching records of hepatitis C-related deaths in HES to death
certiﬁcates, we estimated that, between 2000 and 2005, the true number of deaths from
hepatitis C-related end-stage liver disease was between 185% (353/124) and 257% (378/106)
higher than the number recorded in routine mortality statistics. We provide estimates of
under-recording that can be used to modify existing models of disease burden due to hepatitis C
and provide a simple approach to improve the monitoring of trends in severe hepatitis C-related
morbidity over time.
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INTRODUCTION
In England and Wales, the age-standardized mor-
tality rates for liver cirrhosis increased by 75% be-
tween 1992 and 2002 [1]. The component of this
burden that can be attributed to hepatitis C, however,
is unclear [2]. Modelling is underway to improve our
understanding of the current and future impact of
chronic liver disease due to hepatitis C in England
[3]. Use of routinely collected data, such as data on
hospital admissions collated in Hospital Episode
Statistics (HES), allows us to estimate and monitor
the number of individuals in England infected with
hepatitis C virus who experience sequelae of their in-
fection. As the number of cases of hepatitis C-related
liver disease will be strongly inﬂuenced by increased
case-ﬁnding and improved investigation of infected
individuals, we chose to monitor cases of end-stage
liver disease (ESLD) that would be expected to spon-
taneously present with signs or symptoms of disease.
The number of such cases identiﬁed in routine data
sources is likely to underestimate the true number of
cases attributed to hepatitis C because of failure to
diagnose hepatitis C as the cause and because of in-
adequate recording and coding of all diagnoses. We
aimed to estimate the under-recording of diagnoses
and deaths due to hepatitis C-related ESLD by HES
and the Oﬃce for National Statistics (ONS).
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METHODS
Data sources and case deﬁnitions
Sentinel surveillance of ESLD
In 2000, the Health Protection Agency Centre for
Infections (HPA CfI) established sentinel surveillance
of ESLD due to viral hepatitis to supplement rou-
tinely collected data [4]. One nominated physicianwith
a special interest in liver disease from each centre re-
ports the number of hepatitis C-infected individuals
(both in-patients and out-patients) presenting for the
ﬁrst time with a symptom of ESLD. Information on
individuals presenting for the ﬁrst time to each hos-
pital with ascites, bleeding varices, hepatic encepha-
lopathy, or primary hepatocellular carcinoma due to
hepatitis C are reported monthly by the nominated
physician to the HPA CfI. Evidence of hepatitis C
virus infection is deﬁned as a positive test for antibody
to hepatitis C virus or for hepatitis C virus RNA. The
case deﬁnition was chosen in collaboration with ex-
perienced physicians to identify individuals with sev-
ere enough complications to present spontaneously
to a hospital with clinical manifestations of liver dis-
ease. This deﬁnition, based solely on clinically ap-
parent signs or symptoms, was considered unlikely to
be inﬂuenced by increased case-ﬁnding for hepatitis
C, accompanied by active investigation (such as liver
biopsy) of such cases.
Participating centres have included a range of
hospitals, from specialist liver transplant centres to
district general hospitals, in a range of regions. To en-
courage complete reporting clinicians are requested to
report to us each month, even if no cases ﬁtting the
case deﬁnition have been seen. Information extracted
from the database included hospital, month and year
of birth, sex, diagnosis, and date of presentation.
Mortality data from death certiﬁcates
Information was available from the death certiﬁcates
of patients who died between 2000 and 2005 with any
mention of hepatitis C in the text or presence of an
ICD10 code for hepatitis C (B17.1 or B18.2) in any of
the 13 ﬁelds supplied by the ONS [5]. These data are
provided on request to the HPA CfI for use as part
of national surveillance. Deaths due to hepatitis C-
related ESLD were deﬁned as those for which there
was mention of severe liver disease or hepatocellular
carcinoma in the text or in the ICD10 codes (R18,
K72.9, K72.0, K72.1, K70.4, I85.0, I85.9, I98.2,
C22.0) on the certiﬁcate. The code for acute hepatitis
was included after review of the death certiﬁcates for
all deaths with ICD codes found that none speciﬁed
an acute infection in the text entries. This suggests
that where chronic infection is not speciﬁed, the code
for acute infection is used as a default by ONS. Place
of death was available for all records and each death
was categorized as having occurred in hospital or out
of hospital.
HES
Information on individuals diagnosed with, and who
died from, severe liver disease due to hepatitis C was
available from HES recorded between 1 April 1997
and 31 March 2006 [6]. HES contain separate records
for each episode of hospital care that an individual
receives within a given admission to a National
Health Service (NHS) hospital in England. Each HES
record contains clinical, demographic, administrative,
and geographical information about an individual
patient. Data are supplied to the HPA in an anon-
ymized form, therfore it is not possible to validate the
accuracy of clinical or other coding. A person was
deﬁned as having been diagnosed in HES with ESLD
if one or more of their episodes included an ICD10
code for ascites, bleeding varices, or hepatic encepha-
lopathy (R18, K72.9, K72.0, K72.1, K70.4, I85.0,
I85.9, I98.2) or hepatocellular carcinoma (C22.0)
in any of the 14 diagnosis ﬁelds. These episodes
were then matched using the unique identiﬁer ﬁeld
(HESID) to all episodes coded to hepatitis C (ICD10
codes B17.1 or B18.2) within the same ﬁnancial
year to identify those likely to be diagnosed with
hepatitis C-related ESLD. The ICD10 code for acute
hepatitis C was included because of our experience
with ONS data.
To identify individuals newly presenting with
hepatitis C-related ESLD, the individuals diagnosed
as above were de-duplicated using HESID, to identify
the ﬁrst date of admission for each individual. To
avoid including individuals whose ﬁrst admission for
hepatitis C-related severe liver disease occurred prior
to April 1997, only individuals with ﬁrst admission
dates between 2000 and 2005 were analysed. It was
therefore assumed that it was unlikely that individuals
diagnosed with ESLD disease prior to April 1997
would then be admitted after January 2000 without
any intervening care. To identify individuals where
hepatitis C-related ESLD contributed to death, in-
dividuals diagnosed with hepatitis C-related ESLD
were also matched to all episodes with a death
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recorded in the same ﬁnancial year and with dates of
death between 2000 and 2005.
Statistical methods
Pooling data over the years 2000–2005, records for
individuals who ﬁrst presented with ESLD related to
hepatitis C in one of the sentinel centres were matched
between the sentinel surveillance and HES on month
and year of birth, sex, and hospital provider code. For
centres that did not participate in the sentinel sur-
veillance scheme for the whole period, cases were
matched to individuals in HES only for the period of
participation.
Deaths with hepatitis C-related ESLD recorded
in HES and registered by the ONS were matched
on month and year of birth, date of death, and sex.
Individuals without date of birth and sex were necess-
arily excluded from the matching exercise. Matching
records were checked by hand for additional infor-
mation (such as place of death, date of admission,
ethnic status) to corroborate the match.
A capture–recapture analysis was undertaken to
estimate the total number of diagnoses of hepatitis
C-related severe liver disease in participating centres.
A second capture–recapture analysis was conducted
to estimate the total number of deaths due to severe
liver disease and hepatitis C in English hospitals. Esti-
mates of the total number individuals diagnosed with,
and who died from, severe liver disease due to hepa-
titis C (e) were calculated using the formula given in
Table 1.
Goodness-of-ﬁt-based conﬁdence intervals were
calculated using the method of Regal & Hook [7]. All
analyses were done using Stata statistical software
(version 8.2, Stata Corp, College Station, TX, USA)
and Microsoft Excel (Microsoft, Redmond, WA,
USA).
A sensitivity analysis was performed to calculate
the total number of individuals diagnosed, or dying,
with hepatitis C-related severe liver disease assuming
that we failed to detect 5%of true matches (false nega-
tives) and assuming 5% of the matches were not, in
fact, the same individual (false positives).
RESULTS
Sentinel surveillance and HES
Between 2000 and 2005, nine English centres partici-
pated for between 1 and 6 years, returning a total of
377/468 (80%) of the expected monthly returns. A
total of 247 cases due to hepatitis C were reported to
sentinel surveillance from these collaborating centres,
compared to 419 recorded in HES for the same cen-
tres (Table 2). After excluding 11 cases with missing
date of birth and ﬁve duplicates from HES, 166 cases
werematched between both datasets (leaving 80ESLD
and 237 HES cases that did not match), making the
total estimated cases in that period to be 597 [95%
conﬁdence interval (CI) 562–642]. Sensitivity analysis
assuming 5% false-positive and 5% false-negative
matches gives a total estimated number of cases of
629 (95% CI 587–679) and 570 (95% CI 540–608),
respectively.
The cases reported via ESLD that matched to cases
in HES were similar to those that did not match in
terms of sex, diagnosis and age. The proportion of
cases in males was 128/166 (77%) and 60/80 (75%),
and with a diagnosis of hepatocellular cancer was 55/
166 (33%) and 31/80 (39%) in matching and non-
matching cases, respectively. The mean age of match-
ing cases was 53 years compared to 55 years in those
that did not match.
Mortality: HES and ONS
A total of 935 deaths were reported to ONS in the
period, one was excluded from the matching because
of missing date of birth. Of the remaining 934, 740
had a hospital as place of death. In the same period
1362 deaths were reported in HES, 16 were excluded
from matching due to missing dates of birth and two
were found to be duplicates, leaving 1344 available for
matching. A total of 417 cases matched between the
two datasets, leaving 927 deaths reported only to HES
and 323 only to ONS (Table 3).
The ONS deaths that matched to deaths in HES
were similar to those that did not match in terms of
sex, diagnosis and age. The proportion of cases in
males was 319/417 (76%) and 222/323 (69%), and
with a diagnosis of hepatocellular cancer was 150/
417 (36%) and 121/323 (38%) in matching and
Table 1. The capture–recapture method
Dataset A
Present Absent Total
Dataset B
Present a b
Absent c d=b*c/a
Total e=a+b+c+d
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non-matching deaths, respectively. The mean age of
both groups was 56 years.
DISCUSSION
The yearly number of new cases of hepatitis C virus
infection in England is estimated to have increased
from about nil in 1960 to around 12000 in 1995 [3].
To inform health-care planning for hepatitis C and to
make the case for providing resources for the treat-
ment of hepatitis C virus-infected individuals it is vital
to know the current and future burden of infection.
Routinely collected data, including HES and death
certiﬁcates, can be used to monitor the number of di-
agnoses of, and deaths from, hepatitis C. However, as
shown in the present study, these sources of data
underestimate the burden of disease. Using capture–
recapture techniques, we suggest that the total num-
ber of individuals diagnosed with hepatitis C-related
ESLD in England is around 42% higher than the
number reported in HES and the total number of in-
dividuals who die with this condition in hospital is
more than 200% higher than the number recorded by
ONS. Any estimates of the future burden of hepatitis
C and severe liver disease using routine data sources
needs to adjust for under-reporting and any analysis
of trends need to account for possible changes in
under-reporting over time.
Capture–recapture techniques have been used for a
number of diseases to estimate the level of ‘missing’
data in routine sources [8–11]. There are four main
assumptions underlying this technique: that the under-
lying population from which the individuals are
drawn remains unchanged during the study period,
that the lists of individuals being compared are inde-
pendent, that each member of the population has the
same probability of being on a given list, and that
individuals are matched correctly [12, 13]. It is also
important that the case deﬁnition for each list has a
high speciﬁcity (i.e. a low false positivity rate), other-
wise capture–recapture methods will overestimate the
burden of disease [9].
The underlying populations for this study were the
catchment populations of the sentinel centres and re-
sidents of England. Although there will be some
changes in both of these populations, given the severe
and uncommon nature of the disease studied, changes
within the period are unlikely to be signiﬁcant enough
to inﬂuence this analysis. We will have missed some
true matches as cases may have been reported to the
other data source outside of the study period and weT
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may have matched incorrectly due to the limited
identiﬁers available in HES. However, assuming that
¡5% cases should have been matched did not ma-
terially alter our conclusions. To minimize the possi-
bility of including cases of ESLD which are not truly
hepatitis C-related we chose a clinically speciﬁc case-
deﬁnition and required the hospitalized cases to be
recorded with a diagnosis of hepatitis C in the same
ﬁnancial year. However, we were not able to validate
diagnostic coding in HES and it is possible that in
some cases there was another cause for the severe liver
disease (such as alcohol) and that hepatitis C virus
infection was not thought to have contributed to the
condition. We assumed, however, that in anyone di-
agnosed with hepatitis C and symptoms of ESLD in
the same ﬁnancial year, hepatitis Cwas either causal or
contributing to morbidity, for example as a co-factor
with alcohol.
We cannot exclude the possibility that a person’s
probability of being on one list is dependent on their
probability of being on the second list. A diagnosed
patient not ascertained in HES (e.g. because the re-
sults of their hepatitis C test were not included in their
hospital records) may also be unlikely to have been
reported via sentinel surveillance. However, partici-
pating clinicians with an interest in viral hepatitis are
likely to actively seek hepatitis test results for a pa-
tient seen with a life-threatening liver-related con-
dition and so we feel that this is unlikely to be a major
problem in the sentinel surveillance. A clinician who
completes a death certiﬁcate, however, may use only
the information recorded in the notes and so it is
likely that there is some dependency between death
certiﬁcates and hospital episodes. Another potential
limitation is the possibility of heterogeneity, where
particular members of the population may be less
likely to appear on a given list. Certain groups of in-
dividuals may be less likely to have an episode coded
as hepatitis C-related when seeking hospital care,
perhaps because of concerns about stigma or in-
surance risks. However, comparison of those matched
with those reported only to sentinel surveillance or
recorded by the ONS suggested that the two groups
were largely similar.
These limitations may have produced an over- or
underestimate of the total burden of hepatitis C-
related disease. It is plausible that failure to match be-
cause of missing or incorrect identiﬁers has occurred,
or that certain groups are less likely to appear on
certain lists, leading to an overestimate of total cases
or deaths. In contrast, possible dependency between
the data sources used may have led to an underesti-
mate of total burden. Importantly, both datasets
exclude individuals where the diagnosis, of either
hepatitis C or severe liver disease, has never been
made. This problem should have been minimized by
the choice of a case deﬁnition of severe disease, which
would normally warrant intensive investigation, in-
cluding hepatitis C testing. However, individuals who
present and die quickly before investigations can be
performed may not be diagnosed and will therefore
not be included in either dataset. This may be par-
ticularly true for individuals where other more com-
mon aetiological factors, such as alcohol, are present.
The number of individuals with less severe manifes-
tation of hepatitis C infection, such as early cirrhosis,
is likely to be underestimated to a much greater ex-
tent.
Despite the limitations we have discussed, we
believe that our results provide an estimate of
Table 3. The estimated total number of individuals in England dying with hepatitis C-related severe liver
disease, 2000–2005
ONS deaths
HES
deaths
Capture–recapture analysis
Total
In
hospital
ONS
only
HES
only
HES
and
ONS
Total estimated
deaths in hospital
(95% CI)
5% false positive
(95% CI)
5% false negative
(95% CI)
2000 152 124 168 65 109 59 353 (310–416) 372 (323–443) 329 (293–385)
2001 139 114 186 50 122 64 331 (295–383) 349 (307–406) 310 (281–356)
2002 133 106 203 49 146 57 378 (331, 446) 397 (346–476) 348 (309–403)
2003 157 124 228 59 163 65 435 (383–509) 458 (399–538) 401 (356–458)
2004 169 131 252 47 168 84 393 (359–441) 414 (373–467) 369 (342–412)
2005 185 141 307 53 219 88 492 (447–554) 518 (465–585) 457 (419–506)
2000–2005 934 740 1344 323 927 417 2385 (2268–2519) 2511 (2380–2663) 2219 (2122–2333)
HES, Hospital Episode Statistics ; ONS, Oﬃce for National Statistics ; CI, conﬁdence interval.
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under-ascertainment that may be useful for model-
ling. They also provide a mechanism for monitoring
trends and for validating predictions based on pre-
vious models. With this new information we will be
better able to inform health-care planning and the
targeting of scarce resources within the NHS.
APPENDIX. HPA Sentinel Surveillance Scheme
T. Woodall, G. Alexander (Addenbrooke’s Hospital,
Cambridge, UK) ; J. Collier, R. Chapman (John Rad-
cliﬀeHospital, Oxford,UK) ;M. Farrant (RoyalUnited
Hospital, Bath, UK) ; N. Tatman, N. Naoumov (Uni-
versity College Hospital, London, UK) ; A. Clements,
M. Cramp (Derriford Hospital, Plymouth, UK) ; A.
Brind (Stoke City General Hospital, Stoke, UK) ; S.
Solaiman, G. Foster (Royal London Hospital, London,
UK) ; S. Ryder (Queens Medical Centre, Nottingham,
UK) ; J. Green (Llandough Hospital, Cardiﬀ, UK).
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